277 related articles for article (PubMed ID: 24488495)
21. NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.
Yao Z; Xing L; Boyce BF
J Clin Invest; 2009 Oct; 119(10):3024-34. PubMed ID: 19770515
[TBL] [Abstract][Full Text] [Related]
22. RelB/NF-κB2 regulates corticotropin-releasing hormone in the human placenta.
Wang B; Parobchak N; Rosen T
Mol Endocrinol; 2012 Aug; 26(8):1356-69. PubMed ID: 22734038
[TBL] [Abstract][Full Text] [Related]
23. Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.
Tao Y; Liu Z; Hou Y; Wang S; Liu S; Jiang Y; Tan D; Ge Q; Li C; Hu Y; Liu Z; Chen X; Wang Q; Wang M; Zhang X
Oncogene; 2018 Nov; 37(44):5887-5900. PubMed ID: 29973688
[TBL] [Abstract][Full Text] [Related]
24. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
25. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers.
Bonizzi G; Bebien M; Otero DC; Johnson-Vroom KE; Cao Y; Vu D; Jegga AG; Aronow BJ; Ghosh G; Rickert RC; Karin M
EMBO J; 2004 Oct; 23(21):4202-10. PubMed ID: 15470505
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of tumor progression locus 2 protein kinase suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis through down-regulation of the c-Fos and nuclear factor of activated T cells c1 genes.
Hirata K; Taki H; Shinoda K; Hounoki H; Miyahara T; Tobe K; Ogawa H; Mori H; Sugiyama E
Biol Pharm Bull; 2010; 33(1):133-7. PubMed ID: 20045951
[TBL] [Abstract][Full Text] [Related]
27. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
28. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription.
Kane LP; Mollenauer MN; Xu Z; Turck CW; Weiss A
Mol Cell Biol; 2002 Aug; 22(16):5962-74. PubMed ID: 12138205
[TBL] [Abstract][Full Text] [Related]
29. Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.
Choudhary S; Boldogh S; Garofalo R; Jamaluddin M; Brasier AR
J Virol; 2005 Jul; 79(14):8948-59. PubMed ID: 15994789
[TBL] [Abstract][Full Text] [Related]
30. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
31. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
Müller JR; Siebenlist U
J Biol Chem; 2003 Apr; 278(14):12006-12. PubMed ID: 12556537
[TBL] [Abstract][Full Text] [Related]
32. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways.
Hu JP; Nishishita K; Sakai E; Yoshida H; Kato Y; Tsukuba T; Okamoto K
Eur J Pharmacol; 2008 Feb; 580(1-2):70-9. PubMed ID: 18083161
[TBL] [Abstract][Full Text] [Related]
33. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
Remouchamps C; Dejardin E
Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid receptor signaling contributes to constitutive activation of the noncanonical NF-κB pathway in term human placenta.
Wang B; Palomares K; Parobchak N; Cece J; Rosen M; Nguyen A; Rosen T
Mol Endocrinol; 2013 Feb; 27(2):203-11. PubMed ID: 23239753
[TBL] [Abstract][Full Text] [Related]
35. Gypenoside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB, AKT, and MAPK signaling pathways.
Han J; Gao W; Su D; Liu Y
J Cell Biochem; 2018 Sep; 119(9):7310-7318. PubMed ID: 29797602
[TBL] [Abstract][Full Text] [Related]
36. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL.
Huang H; Ryu J; Ha J; Chang EJ; Kim HJ; Kim HM; Kitamura T; Lee ZH; Kim HH
Cell Death Differ; 2006 Nov; 13(11):1879-91. PubMed ID: 16498455
[TBL] [Abstract][Full Text] [Related]
37. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y
J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840
[TBL] [Abstract][Full Text] [Related]
39. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
40. p100 Deficiency is insufficient for full activation of the alternative NF-κB pathway: TNF cooperates with p52-RelB in target gene transcription.
Lovas A; Weidemann A; Albrecht D; Wiechert L; Weih D; Weih F
PLoS One; 2012; 7(8):e42741. PubMed ID: 22880094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
